Homologous recombination deficiency in triple-negative breast cancer: Multi-scale transcriptomics reveals distinct tumor microenvironments and limitations in predicting immunotherapy response
Kai Kang et al, 2023, Computers in Biology and Medicine CrossRef
Obesity-associated changes in molecular biology of primary breast cancer
Ha-Linh Nguyen et al, 2023, Nature Communications CrossRef
Autophagy modulates FSS‐induced epithelial–mesenchymal transition in hepatocellular carcinoma cells
Guanyue Su et al, 2021, Molecular Carcinogenesis CrossRef
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
Arpit Dave et al, 2023, Cellular Oncology CrossRef
Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma
Ying Chen et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
Single-cell transcriptomic analysis uncovers the origin and intratumoral heterogeneity of parotid pleomorphic adenoma
Xiuyun Xu et al, 2023, International Journal of Oral Science CrossRef
Mucinous metaplasia in Pten conditional knockout mice and mucin family genes as prognostic markers for prostate cancer
Nilton J. Santos et al, 2022, Life Sciences CrossRef
Unravelling cancer subtype-specific driver genes in single-cell transcriptomics data with CSDGI
Meng Huang et al, 2023, PLOS Computational Biology CrossRef
The analysis of transcriptomic signature of TNBC—searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity
Supplitt Stanislaw et al, 2024, Journal of Applied Genetics CrossRef
Evaluation of triple negative breast cancer with heterogeneous immune infiltration
Ángela Quintana et al, 2023, Frontiers in Immunology CrossRef
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
Hui Hao et al, 2023, Open Life Sciences CrossRef